1,497 results on '"van Gelder, Isabelle C"'
Search Results
2. Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm: INSTANT Phase 2 Trial
3. Ancillary pharmacological treatment options
4. Epidemiology and modifiable risk factors for atrial fibrillation
5. Atrial fibrillation: better symptom control with rate and rhythm management
6. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials
7. Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry
8. Mobile app-based symptom-rhythm correlation assessment in patients with persistent atrial fibrillation
9. Association between comorbidities and left and right atrial dysfunction in patients with paroxysmal atrial fibrillation: Analysis of AF-RISK
10. High heart rates during paroxysmal atrial fibrillation: continuous rhythm monitoring data of the RACE V study.
11. Managing elderly patients with atrial fibrillation and multimorbidity: call for a systematic approach.
12. Author Correction: Epidemiology and modifiable risk factors for atrial fibrillation
13. Previous Exercise Levels and Outcome in Patients with New Atrial Fibrillation: ‘Past Achievements Do Not Predict the Future’
14. Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
15. Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial
16. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD)
17. Risk Factors for Atrial Fibrillation Progression
18. Longer and better lives for patients with atrial fibrillation : the 9th AFNET/EHRA consensus conference
19. Longer and better lives for patients with atrial fibrillation:the 9th AFNET/EHRA consensus conference
20. Cardioversion strategy impacts rate control during recurrences in patients with paroxysmal atrial fibrillation:A subanalysis of the RACE 7 ACWAS trial
21. Abstract 12420: Orally Inhaled Flecainide for the Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm: Final Results From the Phase 2 Instant Trial
22. Unexplained Atrial Myopathy and Sick Sinus Syndrome in a Young Patient with Atrial Fibrillation
23. Multimorbidity in patients with atrial fibrillation.
24. Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective
25. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials
26. Women have less progression of paroxysmal atrial fibrillation: data from the RACE V study
27. Segment length in cine (SLICE) strain analysis: a practical approach to estimate potential benefit from cardiac resynchronization therapy
28. Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome
29. Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm
30. Dynamic biomarker profiles in patients with paroxysmal atrial fibrillation: Assessing the differences between sinus rhythm and acute atrial fibrillation episode
31. Cardioversion strategy impacts rate control during recurrences in patients with paroxysmal atrial fibrillation: A subanalysis of the RACE 7 ACWAS trial
32. Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial
33. Safety and efficacy of antiarrhythmic drugs
34. Contributors
35. Rate control of atrial fibrillation
36. Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey)
37. Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
38. Right Heart Dysfunction in Heart Failure With Preserved Ejection Fraction: The Impact of Atrial Fibrillation
39. Renal sympathetic denervation induces changes in heart rate variability and is associated with a lower sympathetic tone
40. Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop
41. Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
42. Multimorbidity management in atrial fibrillation: The Polish perspective in the EHRA-PATHS study
43. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume
44. Atrial Fibrillation During Cardiac Resynchronization Therapy
45. Cardioversion strategy impacts rate control during recurrences in patients with paroxysmal atrial fibrillation: A subanalysis of the RACE 7 ACWAS trial.
46. Rate control in atrial fibrillation, calcium channel blockers versus beta-blockers.
47. Abstract 15742: An Open-label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution Shows Acute Conversion of Recent-onset, Symptomatic Atrial Fibrillation to Sinus Rhythm in a Dose- and Concentration-dependent Manner
48. Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation
49. Sex Differences in Early Rhythm Control of Atrial Fibrillation in the EAST-AFNET 4 Trial
50. Multi-ethnic genome-wide association study for atrial fibrillation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.